Transcription factors (TFs) are proteins that regulate gene expression by binding DNA and recruiting other proteins or by affecting chemical changes on other proteins or DNA. To function properly, TFs require interaction with other proteins and protein complexes. TFs can bind varied genomic regulatory regions, such as enhancers, and cause differences in expression patterns of protein coding genes as well as the non-coding genome. TFs regulate gene expression in all human cells from the zygote onwards, yet very little is known about the activity of TFs during preimplantation development. Embryonic genome activation (EGA) is a major genomic event, during which the embryos own genome is activated as a primary source of transcription. EGA involves large scale genomic reorganization and major changes in gene expression patterns and biochemical processes. In previous research, paired-like homeobox family (PRDL) TFs were implicated as potential transcriptional regulators of EGA. The overall aim of this thesis was to characterize little known proteins potentially involved in EGA using data-driven multiomics methods combining transcriptomics, genomics and proteomics. In the first publication, multiomics analysis revealed PRDL TF LEUTX as a potent transcriptional activator. LEUTX stably interacts with the EP300 and CBP histone acetyltransferases through its 9 amino acid transactivation domain, and deletion of this domain abolishes the interaction. LEUTX also interacted with multiple chromatin modifying complexes, such as the E2F6-complex. LEUTX genomic binding sites notably overlapped with enhancer regions, including novel enhancers not previously identified in other studies. LEUTX was found to upregulate several genes linked to preimplantation development, epigenetic regulation as well as 8-cell-like markers. In the second publication, a comprehensive interactome analysis of PRDL TFs identified more than a thousand high-confidence interactions for the 21 studied TFs with more than 300 interacting proteins. PRDL TFs were shown to interact with a large number of epigenetic regulators and developmental proteins. Coupled with protein DNA binding analysis, it also established that TPRX2, currently assigned as pseudogene, is a transcriptional activator. In the third publication, a multiomics analysis of the pioneering TF DUX4 revealed DUX4 is a potent chromatin modifier and transcriptional activator of both coding and non-coding DNA. Interactome analysis of DUX4 showed DUX4 interacts with multiple chromatin modifying complexes and directly with the Mediator complex. DUX4 expression leads to wide scale changes in the chromatin landscape, upregulation of cleavage stage TFs and upregulation of several novel enhancers as well as repetitive elements.